miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells. - Test2 - elhamkhani - TriplyDB

miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells.

miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells.

http://www.wikidata.org/entity/Q37611689

about

Use of Mature miRNA Strand Selection in miRNAs Families in Cervical Cancer Development.MicroRNA-20a contributes to cisplatin-resistance and migration of OVCAR3 ovarian cancer cell line.MicroRNAs in gynecological cancers: Small molecules with big implications.Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells.Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.Circular RNAs and hereditary bone diseases.miR-25 modulates triacylglycerol and lipid accumulation in goat mammary epithelial cells by repressing PGC-1beta.MicroRNA-217 functions as a tumor suppressor in cervical cancer cells through targeting Rho-associated protein kinase 1 STAT3 regulated promotes ovarian cancer proliferation and cisplatin resistance

P2860

Q37690967-41BD2F3D-7429-44DC-8537-937B37724F56 Q38695476-F6909AE4-89C8-4169-B589-1C82689BFD6C Q39333266-C8399C2A-BFF3-45AA-9FDD-D372EE4045F9 Q41595470-25C2A79B-E71C-44F3-99EF-E3512F0A8362 Q52647903-67AB7F4A-00FC-454D-B160-87F70BC9E88D Q53701140-91D95BD2-1654-48CB-9A9E-F8C64D6833AF Q55374764-2E88F56D-5511-41D9-819E-816F932CCAA9 Q57788850-1EBFECD3-7BBA-4837-B527-3DDE2CF6E535 Q58693575-7F60F35E-D3BA-478C-8605-E152407C4D20

P2860

miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells.

http://www.wikidata.org/entity/Q37611689

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

miR-25-3p reverses epithelial- ...... istance cervical cancer cells.

@en

miR-25-3p reverses epithelial- ...... istance cervical cancer cells.

@nl

type

label

miR-25-3p reverses epithelial- ...... istance cervical cancer cells.

@en

miR-25-3p reverses epithelial- ...... istance cervical cancer cells.

@nl

prefLabel

miR-25-3p reverses epithelial- ...... istance cervical cancer cells.

@en

miR-25-3p reverses epithelial- ...... istance cervical cancer cells.

@nl

P1433

Q37611689-A5B07716-C90E-4F80-B64D-8F039557C782

P1476

Q37611689-D72ADD17-AA9B-4993-82D1-FE6BB1423BC8

P2093

Q37611689-836946CA-D86B-48D5-A1DC-262F030A0F08

Q37611689-F89EF58B-741E-4BF7-8DE2-E7C86B328E55

P2860

Q37611689-00144D42-FCA7-4FE8-809A-5A82366170E2

Q37611689-01AAF210-D6D8-4CA1-B1A7-D82431BB2AD7

Q37611689-03AABB71-9AD0-4A94-B4B7-2CC79057F71D

Q37611689-111B5C83-FB4B-49EE-B89E-6919D553265D

Q37611689-12B61B80-C2C6-4C24-A266-67E038DADF21

Q37611689-12E5D770-D6B5-40B7-BCCF-F41415481B90

Q37611689-13713A8A-AFB1-46DC-847E-CC3E6BB6719A

Q37611689-17FCACDC-96C9-4051-9FB0-85235F0EA48F

Q37611689-19582783-84DC-485B-B130-EAFBC05C6738

Q37611689-2582503A-46FB-47C5-BD5C-FB3B704147C7

P304

Q37611689-EEEEB7DA-85E9-4826-8FC4-B6A6B5B43CF4

P31

Q37611689-27F23266-8ACE-4720-9748-F3434968FE0B

P356

Q37611689-4BC9D359-7139-4F63-9D1F-C9C0B1DEFE9B

P433

Q37611689-95ECAC30-47D3-4C02-BE94-1BB20C8F1439

P478

Q37611689-8D0015C6-8F5C-4E66-B266-C014459591DB

P577

Q37611689-B089DB2D-9F81-41C6-A60E-4E90FED3B8D4

P698

Q37611689-1CBD7B4A-A76F-4CD4-9027-64F34343A3E8

P932

Q37611689-2DE50F26-77A7-4670-BBF0-BA3D7C6C1809

P356

P1433

P1476

miR-25-3p reverses epithelial- ...... istance cervical cancer cells.

@en

P2093

Jing Song

http://www.w3.org/2001/XMLSchema#string

Yue Li

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

Molecular mechanisms of epithelial-mesenchymal transition

Epithelial-mesenchymal transitions in development and disease

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study

Knockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistance.

Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

P304

23-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13104

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27743413

http://www.w3.org/2001/XMLSchema#string

P932

5276840

http://www.w3.org/2001/XMLSchema#string